Development of Biomarkers or Composite Biomarkers for Neurological and Neuromuscular Disorders (R61/R33 - Clinical Trial Optional) vs Emerging Infections Network - Research for Preventing, Detecting, and Managing Travel-associated Infectious Diseases
Side-by-side comparison of two grants.
| Attribute | Development of Biomarkers or Composite Biomarkers for Neurological and Neuromuscular Disorders (R61/R33 - Clinical Trial Optional) | Emerging Infections Network - Research for Preventing, Detecting, and Managing Travel-associated Infectious Diseases |
|---|---|---|
| Type | Grant | Grant |
| Funding amount | — | $6M |
| Deadline | Closes 2028-01-07 | Closes 2026-11-05 |
| Region | US | US |
| Sector | Health | Health |
| Funder | National Institutes of Health | Centers for Disease Control and Prevention - ERA |
| Who it's for | researchers, students, government | researchers, students |
noindex — no measured search demand